Skip to content

Optimization scheme research of step by step target controlled induction of propofol on the loss of consciousness and the hemodynamics in eldly patients

Optimization scheme research of step by step target controlled induction of propofol on the loss of consciousness and the hemodynamics in eldly patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOD-16010041
Enrollment
Unknown
Registered
2016-11-29
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

eldly patients

Interventions

one:2.0ng/ml remifentanil, 1.0ug/ml propofol
two:2.0ng/ml remifentanil, 1.5ug/ml propofol
three:2.0ng/ml remifentanil,2.0ug/ml propofol
four:3.0ng/ml remifentanil, 1.0ug/ml propofol
five:3.0ng/ml remifentanil, 1.5ug/ml propofol
six:3.0ng/ml remifentanil, 2.0ug/ml propofol

Sponsors

Anhui provincial hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 79 Years

Inclusion criteria

Inclusion criteria: Aged 65-79 years, ASA grade I ~ III patients, scheduled for elective surgery in general anesthesia, and are expected to stay in hospital for observation treatment over 48h; All patients have signed informed consent. All patients are not combined with no serious candic, cerebral and respitory disease, no serious liver and kidney dysfunction, no history of mental illness, with no unconsciousnes.

Exclusion criteria

Exclusion criteria: The body mass index (BMI) 30 kg/m2; the patients with abnormal liver and kidney function (ALT) or (AST) more than 1.5 times the upper limit of the normal value; creatinine greater than 1.5 times the upper normal limit or dialysis treatment within one month before the operation; heart and lung function of severe organic diseases (such as severe heart valvular disease, cardiac ejection fraction <55%, need to install the pacemakers in various kinds of arrhythmia, atrial fibrillation, pulmonary function damage etc.); the hearing impairment; the related drug allergy medication; the 24h before taking diazepam, opioid analgesic substance; the preoperative fasting time have obvious dehydration and electrolyte disorders; Other researchers believe that the situation is not suitable for clinical trials.

Design outcomes

Primary

MeasureTime frame
time;blood pressure;heart rate;BIS value;Propofol plasma and effect compartment concentration;

Countries

China

Contacts

Public ContactWei Xin

Anhui provincial hospital

kekaiyuan628@126.com+86 13956975101

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026